Display search results for ** instead (39 products)
12 Dec 2018  |  North America
Innovation-as-a-service Business Model will Accelerate Growth in the Molecular Diagnostic Subsegment
Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...
26 Dec 2018  |  North America
With the Rise in Focus on Value-based Care, Technology Convergence will Drive Care Delivery Innovation
Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 election...
19 Sep 2018  |  North America
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
21 Jun 2018  |  North America
Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022
Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations
Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...
27 Jun 2018  |  North America
Endoscope Reprocessing Systems and Software Solutions Market Assessment, Australia, Forecast to 2022
The Market for Endoscope Reprocessing Solutions Would be Driven by Increasing Procedural Volumes, Coupled with Increased Demand for Newer Installations as Well as Replacements
The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022. The market is segmented into two broad segments, which are then divided into several sub-segments as mentioned below – • Endosco...
29 Jun 2018  |  North America
Using Cutting-edge Digital Technologies to Improve Patient Engagement and Adherence
Healthcare industry has undergone major transformation in the last decade with the incorporation of digital technologies. The changing technological as well as social trends, which focuses more on consumerism of healthcare which includes personalized interventions, making patients more accountable for their healthcare, disease awareness, is aimed t...
10 Jul 2018  |  North America
Cybersecurity, Artificial Intelligence, Virtual Care, Digital Therapeutics, and the Movements of Major Tech Companies Continue to Advance the Market
At the beginning of this decade, Frost & Sullivan invented the definition of Digital Health to include convergent market segments, such as healthcare information technology (HCIT), remote patient monitoring (RPM), mobile health (mHealth), and telemedicine. Over the last five years, these segments have become increasingly sophisticated as new techno...
28 Sep 2018  |  North America
New Surgical Paradigm to Deliver Value across Markets
This research service offers a strategic perspective of the customer, product, technology and competitors that are influencing the global market for surgical robotics. The report is split into three major sections, each focusing on industry overview, competitive landscape, and voice of stakeholder analysis. The report also includes sections for tec...
28 Sep 2018  |  North America
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
25 Jul 2018  |  North America
Evaluating Growth Patterns and Opportunities Across X-ray Mammography Sets
Over the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer. This has led to significant reduction in mortality and prompted emerging countries to invest in population-based, organized screening. Significant investments in mammography technology have pave...